Showing 1 - 10 of 25
Persistent link: https://www.econbiz.de/10003407302
The paper attempts a critical assessment of both the theory and the empirical evidence on the role of appropriability and in particular of Intellectual Property Right (IPR) as incentives for technological innovation. We start with a critical discussion of the standard justification of the...
Persistent link: https://www.econbiz.de/10003376037
Persistent link: https://www.econbiz.de/10010529929
Persistent link: https://www.econbiz.de/10010354848
Persistent link: https://www.econbiz.de/10010354874
is longer-term evidence that the private sector (essentially big pharma) has decreased its investment in basic research … money did it become eager to undertake applied research, production scale-up and testing. Third, the political economy of …
Persistent link: https://www.econbiz.de/10012803399
is longer-term evidence that the private sector (essentially Big Pharma) has decreased its investment in basic research … money it became eager to undertake applied research, production scale-up and testing. Third, the “political economy” of the …
Persistent link: https://www.econbiz.de/10012520259
The role of the patent system in the pharmaceutical sector is highly debated also due to its strong public health implications. In this paper we develop an evolutionary, agent-based model of the pharmaceutical industry to explore the impact of different configurations of the patent system upon...
Persistent link: https://www.econbiz.de/10012654995
. Conversely, the number of patents protecting new drugs approved by the FDA which draw upon government-sponsored research - as …
Persistent link: https://www.econbiz.de/10012604733
Persistent link: https://www.econbiz.de/10014474366